21 May 2013
Keywords: merck, co, cozaar, share, ace, market, angiotensin
Article | 21 August 1995
- Merck & Co's angiotensin II antagonist Cozaar (losartan) has claimed a
2.5% share of the ACE inhibitor market in the USA, according ...
Enjoying this article? To continue reading you need to login or subscribe.
Subscriptions are £60 per month, pay as you go.
Find out more details.
21 August 1995
14 August 1995
20 May 2013
© 2013 thepharmaletter.com